Vivanti

Official Announcement: Launch of Our UK Operations We are proud to announce our expansion into the UK. As we enter the dynamic fourth quarter, a critical time for the pharmaceutical industry, we are excited to bring our expertise and proven track record to a new market. Our focus includes enhancing digital transformation initiatives across the pharma value chain, advancing commercial excellence, optimising marketing strategies, and developing engaging educational content for healthcare professionals. We are committed to delivering high-value solutions that meet the unique needs of our clients and contribute to their success. Our strategic partnerships have been instrumental in preparing us to escalate our efforts during this period. We invite you to read our detailed launch article to understand how our expansion aligns with broader industry goals and how we can support your growth, activities and initiatives. #UKLaunch #DigitalTransformation #PharmaIndustry #CommercialExcellence #MarketingStrategy #LearningAndDevelopment #Omnichannel #NBA #Metahumans #Chatbots #AIAssistants #GlobalToLocal #ClinicalTrials #CTDs https://lnkd.in/eSTGhwkT

Embracing the AI Revolution in Pharma: Balancing Promise with Prudence. The pharmaceutical and life sciences sectors are embracing AI technologies. According to a comprehensive survey by Elsevier, an impressive 76% of industry professionals are gearing up to integrate AI into their operations within the next two to five years, drawn by its potential to significantly transform R&D practices. However, alongside this enthusiasm are significant concerns about data integrity and ethical use, sparking a vital conversation about responsible implementation. Mirit Eldor, Managing Director of Life Sciences at Elsevier, highlights the critical role of transparency and accuracy. She advocates for AI tools that are only as good as the data they utilise, stressing the need for high-quality, trustworthy data sources to counter risks of misinformation and boost dependability. To navigate these challenges, our AI experts suggest that the industry should focus on the following: 1- Setting Clear Ethical Standards: Developing robust ethical guidelines tailored to AI use in pharma can steer the development and deployment of these technologies. 2- Boosting Data Transparency: Clarifying data provenance and ensuring transparency in AI operations can help build trust amongst researchers and the broader public. 3- Conducting Thorough Testing: AI systems must undergo extensive testing to confirm they meet high standards of accuracy and reliability before being rolled out. 4- Encouraging Open Conversations: Keeping a continuous dialogue with all stakeholders, including researchers, regulators, and the public, can help address concerns and shape the evolution of AI in a socially responsible way. These steps are essential for leveraging AI's capabilities while mitigating its risks, ensuring that the industry can advance confidently with reliable and ethically sound AI applications. The insights from over 3,000 global researchers paint a vivid picture of an industry excited for change, yet cautious of the road ahead. #AIinPharma #EthicalAI #InnovativeResearch

Design Trends Chapter 7: Embracing Green Design in 2024 Eco-friendly products and organic materials remain a key trend and have become even more prominent in graphic design this year. Explore how Murre Skincare Products incorporate natural elements here: https://lnkd.in/edXaQRd4 Using natural colours, imagery, and an eco-conscious ethos taps into our shared commitment to sustainability. The appeal of 'green design' reflects an appreciation for nature and a dedication to environmentally responsible choices. Earthy tones and organic elements are not only a design choice but also an expression of a lifestyle aligned with sustainable values. As we work towards reducing our ecological footprint, green design continues to gain traction, blending visual appeal with a meaningful ethical stance in creative projects. #BioProductDesign #MurreSkincare #GreenDesign #NaturalDesignElements #Vivanti #EcoDesign

Our UK Business Development Manager, Shana Owen, presented our innovative AI-driven solution for simulation training, AVA (part of our AI-driven COSMART Suite), at a conference focused on enhancing commercial excellence. While the presentation primarily highlighted how COSMART AVA enhances the capabilities of Medical Sales Representatives, it is important to recognise the broader applications of simulation training across various aspects of the pharma value chain. With this in mind, we also offer AVA Clinical, which supports healthcare professionals in patient engagement. For example, AVA Clinical could be used for clinical trials, particularly focusing on Diversity, Equity, and Inclusion. This versatility demonstrates how simulation training can make a significant impact wherever engagement is needed. Together, we are paving the way for improved patient outcomes through enhanced training and engagement strategies. #Pharma #HealthcareInnovation #COSMARTAVA #PatientEngagement #SimulationTraining #AI 

We are pleased to announce the launch of our AI-powered training simulator, COSMART AVA, at the 14th Annual Sales Force Effectiveness and Digital Marketing in Pharma Summit hosted by Allan Lloyds in Berlin on 16th October 2024. COSMART AVA is an end-to-end solution that is part of our AI-driven COSMART suite (AVA, NBA, CLM Suite), supporting commercial excellence in a 360-degree manner. Designed to help sales representatives refine their engagement skills with healthcare professionals. The AVA platform simulates real-world interactions, equipping them with essential skills to communicate effectively, handle objections, and build strong relationships in a competitive environment. The feedback from attendees at the summit was incredibly encouraging, reflecting a strong interest in tools that enhance training and performance within the industry. We look forward to exploring opportunities with early adopters who are keen to integrate COSMART AVA into their training programmes. If you would like to learn more about how COSMART AVA can support your team, we invite you to get in touch. #COSMARTAVA #PharmaSales #AITraining #SalesForceEffectiveness #DigitalMarketing #PharmaceuticalIndustry #TrainingSimulator

Vivanti Featured in UK Tech News - Showcasing our flagship solution for commercial excellence. We are thrilled to announce that Vivanti has been featured in UK Healthtech News for our pioneering work in transforming the pharmaceutical and life sciences sectors. Our dedication to leveraging AI-driven solutions and strategic marketing is setting new benchmarks in the industry. As we gear up for the launch of our cutting-edge AI-powered training simulator, COSMART AVA, at the 14th Annual Sales Force Effectiveness and Digital Marketing in Pharma Summit hosted by Allan Lloyds in Berlin on 16th October 2024, we are proud to be at the forefront of enhancing the effectiveness of medical representatives (MRs) in an increasingly competitive environment. Key Highlights from the Article: - COSMART AVA tackles the challenges MRs face in delivering complex medical information and overcoming objections during short interactions with busy healthcare professionals. - The simulator equips MRs with vital skills to communicate critical product knowledge effectively, leading to improved sales performance and stronger relationships with healthcare professionals. Read more about our vision and initiatives in the full article below and stay tuned for more updates on our journey to revolutionise MR training! https://lnkd.in/eh4uY2XH

Pharmaceutical Industry Takes the Lead: Advancing Education and Upskilling Initiatives. The pharmaceutical industry is increasingly recognised not only for its role in advancing medical treatments but also for its pivotal contributions to education and upskilling. Leading this transformative journey are companies like Moderna, Merck KGaA, Darmstadt, Germany, and Eli Lilly and Company, each launching initiatives that bridge the gap between complex scientific knowledge and public understanding. Moderna, in partnership with Coursera, has recently launched a free course on the groundbreaking mRNA technology. This initiative is a prime example of how pharma companies are not just distributing medicines but also knowledge. Merck KGaA also made significant strides by collaborating with the United Nations' Global Initiative on Ageing, offering courses aimed at family carers. These courses are not only multilingual but tailored to equip carers with essential skills and knowledge, thus addressing specific educational needs within the community. Meanwhile, Eli Lilly partnered with Lifeology to create digital flashcards aimed at enhancing public understanding of clinical trials and encouraging diverse participation. Their focus on inclusivity and broadened access to medical research information is a testament to the proactive role pharma can play in educational reform. At Vivanti, we specialise in creating transformative digital learning experiences that complement these industry efforts. Our expertise in Content Creation, Edutainment, Gamification, and Extended Reality helps empower organisations to deliver exceptional educational content that is engaging, informative, and accessible across multiple platforms. #PharmaceuticalIndustry #EducationInitiative #Moderna #Merck #EliLilly #IPOD #DigitalEducation #HealthLiteracy #CommunityEngagement

Beyond Diagnosis: NLP’s Transformative Impact on Healthcare Equity. Recent research from King’s College London, supported by the British Heart Foundation, underscores the significant impact of Natural Language Processing (NLP) on health disparities. The study focused on diagnosing Heart Failure with Preserved Ejection Fraction (HFpEF), which accounts for half of all heart failure cases in the UK, highlighting the crucial role of NLP in improving healthcare equity. In particular, the findings reveal that Black patients benefit from more accurate diagnoses when evaluated using NLP-driven AI tools rather than traditional methods. This illustrates NLP's ability to enhance diagnostic accuracy and reduce ethnic biases in healthcare. HFpEF, characterised by the heart’s ability to pump adequately but with insufficient filling, leads to symptoms such as breathlessness and fatigue. An analysis of electronic medical records of 1,973 patients highlighted noticeable disparities in how patients are diagnosed across different ethnic groups under usual clinical practices. NLP is invaluable in this setting, enabling more nuanced interpretation of complex medical texts and a broader understanding of health data. This approach ensures consideration of a wider range of clinical factors, including atrial fibrillation (commonly found in white and Asian patients) and hypertension, more frequent among Black patients. Beyond improving diagnosis accuracy, NLP can also close communication gaps in healthcare. By adapting patient education and health communications to be culturally appropriate and linguistically tailored, NLP ensures information is accessible and clear to all patients. Furthermore, NLP aids in the efficient collection and analysis of diverse health data, enabling healthcare providers to more effectively pinpoint and tackle disparities. Kevin O'Gallagher, co-lead of the study and a clinician scientist at KCL, advocates for the expanded use of NLP in clinical settings. He believes that utilising such technology can significantly improve how heart failure and other conditions are diagnosed and managed across various populations, thereby aiding in the reduction of healthcare inequalities. This study not only drives advancements in diagnostic tools but also highlights the critical role of technologies like NLP in promoting equitable health outcomes across all communities - something our bespoke, AI-driven technology aims to support and address, particularly within the clinical trial value chain. #NLP #AIinHealthcare #HeartFailure #HealthDisparities #MedicalResearch #KingsCollegeLondon #HeartHealth #PatientDiagnosis #BritishHeartFoundation #ClinicalTrials #ClinicalTrialDEI

Navigating the Challenges of Strategic Storytelling in Pharma Marketing. In the pharmaceutical sector, strategic storytelling serves as an essential marketing tool, enhancing brand engagement and emotional connections. However, effectively leveraging this approach involves navigating a series of complex challenges: 1. Regulatory Compliance: Adhering to the stringent regulations governing pharma marketing is paramount. Stories must not only captivate but also comply with health advertising laws, ensuring all claims are substantiated and accurately reflect the product's approved use. 2. Building Authenticity and Trust: In a sector often viewed with scepticism, maintaining authenticity is key. Pharma brands must craft stories that are not only engaging but also transparent and honest to build and sustain trust with their audience. 3. Standing Out in a Crowded Market: With many brands turning to storytelling, differentiating oneself becomes increasingly difficult. It’s essential to develop unique narratives that clearly communicate the brand's value proposition and resonate with target audiences. 4. Measuring Impact: Quantifying the success of storytelling initiatives can be elusive. Establishing clear metrics for assessing how narratives affect brand perception, customer engagement, and sales is critical for ongoing strategy refinement. 5. Consistency Across Channels: Consistency in storytelling across various platforms ensures the integrity of the brand message. Whether communicated through digital media, print, or direct interactions, the core message must remain uniform and compelling. 6. Engaging Diverse Audiences: Pharma audiences are diverse, including healthcare professionals, patients, and carers, each with distinct needs and viewpoints. Crafting narratives that address these varied audiences while keeping the brand message cohesive is a complex yet vital task. Strategic storytelling in pharma is not just about crafting narratives but about overcoming these challenges to forge deeper connections and drive meaningful engagement. By acknowledging and addressing these hurdles, pharma brands can enhance their storytelling strategies and achieve substantial impact in their marketing efforts. #PharmaMarketing #StrategicStorytelling #HealthcareMarketing #BrandAuthenticity #MarketingChallenges #DigitalTransformation

Part 2/2: Vivanti’s Role in Shaping the Future of Pharma. Building on our first post following our attendance at the Pharma Commercial Digital & SFE Summit by Marxo Smith, we at Vivanti are keen to illustrate how our solutions are addressing significant industry challenges highlighted in the initial post. Driving Innovation in Line with Industry Needs: At Vivanti, we’re in tune with the industry's most pressing demands. We fully support the idea that while AI is transforming healthcare, it needs to work hand in hand with human ingenuity. Our expert medical team partners with our tech and design specialists to develop solutions that not only work but captivate - like our AI-powered avatars for Sales Rep training. Tackling the ""Attention Economy"": Vivanti excels at crafting communications that not only capture attention but also ignite curiosity and build lasting connections. Our multi/omnichannel campaigns have consistently delivered standout results across various markets, demonstrating our capacity to engage effectively with diverse audiences. CRM Excellence: On the CRM front, Vivanti is well equipped. With over 12 years of industry experience, we have a deep understanding of modern CRM systems and how to unlock their full potential. Our "next best action" solution, adaptable to any CRM, ensures smooth access to information and boosts communication across teams. A Convergence of Innovation and Expertise: The fusion of technology and human insight is more crucial than ever in steering the future of healthcare. At Vivanti, our dedication to this fusion drives every innovation and every solution we develop. We are thankful for the community’s engagement and the spirit of collaboration at the summit, which continue to inspire our mission to advance healthcare through innovation. Here’s to continuing to shape an industry where technology and human expertise combine to enhance patient outcomes.  If you missed the initial post, check it out here: https://lnkd.in/ecYN5a8R) #VivantiInnovation #CRMExcellence #PharmaIndustry